1 |
Carroll LA, Hanasono MM, Mikulec AA, et al. Triamcinolone stimulates bFGF production and inhibits TGF-beta1 production by human dermal fibroblasts. Dermatol Surg 2002;28:704-9.
DOI
|
2 |
Shah M, Foreman DM, Ferguson MW. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci 1995;108(Pt 3):985-1002.
|
3 |
Ahn ST, Monafo WW, Mustoe TA. Topical silicone gel for the prevention and treatment of hypertrophic scar. Arch Surg 1991;126:499-504.
DOI
|
4 |
Carney SA, Cason CG, Gowar JP, et al. Cica-Care gel sheeting in the management of hypertrophic scarring. Burns 1994;20:163-7.
DOI
|
5 |
Fulton JE Jr. Silicone gel sheeting for the prevention and management of evolving hypertrophic and keloid scars. Dermatol Surg 1995;21:947-51.
|
6 |
Cruz-Korchin NI. Effectiveness of silicone sheets in the prevention of hypertrophic breast scars. Ann Plast Surg 1996;37:345-8.
DOI
|
7 |
Hanasono MM, Lum J, Carroll LA, et al. The effect of silicone gel on basic fibroblast growth factor levels in fibroblast cell culture. Arch Facial Plast Surg 2004;6:88-93.
DOI
|
8 |
Tandara AA, Kloeters O, Mogford JE, et al. Hydrated keratinocytes reduce collagen synthesis by fibroblasts via paracrine mechanisms. Wound Repair Regen 2007;15:497-504.
DOI
|
9 |
Gallant-Behm CL, Mustoe TA. Occlusion regulates epidermal cytokine production and inhibits scar formation. Wound Repair Regen 2010;18:235-44.
DOI
|
10 |
Kuhn MA, Moffit MR, Smith PD, et al. Silicone sheeting decreases fibroblast activity and downregulates TGFbeta2 in hypertrophic scar model. Int J Surg Investig 2001;2:467-74.
|
11 |
Ricketts CH, Martin L, Faria DT, et al. Cytokine mRNA changes during the treatment of hypertrophic scars with silicone and nonsilicone gel dressings. Dermatol Surg 1996;22:955-9.
|
12 |
Babu M, Diegelmann R, Oliver N. Keloid fibroblasts exhibit an altered response to TGF-beta. J Invest Dermatol 1992;99:650-5.
DOI
|
13 |
Moulin V. Growth factors in skin wound healing. Eur J Cell Biol 1995;68:1-7.
|
14 |
Niessen FB, Andriessen MP, Schalkwijk J, et al. Keratinocyte-derived growth factors play a role in the formation of hypertrophic scars. J Pathol 2001;194:207-16.
DOI
|
15 |
Tredget EE. The molecular biology of fibroproliferative disorders of the skin: potential cytokine therapeutics. Ann Plast Surg 1994;33:152-4.
|
16 |
Garner WL, Karmiol S, Rodriguez JL, et al. Phenotypic differences in cytokine responsiveness of hypertrophic scar versus normal dermal fibroblasts. J Invest Dermatol 1993;101:875-9.
DOI
|
17 |
Dustan HP. Does keloid pathogenesis hold the key to understanding black/white differences in hypertension severity? Hypertension 1995;26:858-62.
DOI
|
18 |
Leof EB, Proper JA, Goustin AS, et al. Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity. Proc Natl Acad Sci U S A 1986;83:2453-7.
DOI
|
19 |
Tan EM, Rouda S, Greenbaum SS, et al. Acidic and basic fibroblast growth factors down-regulate collagen gene expression in keloid fibroblasts. Am J Pathol 1993;142:463-70.
|
20 |
Haisa M, Okochi H, Grotendorst GR. Elevated levels of PDGF alpha receptors in keloid fibroblasts contribute to an enhanced response to PDGF. J Invest Dermatol 1994;103:560-3.
DOI
|
21 |
Hakvoort T, Altun V, van Zuijlen PP, et al. Transforming growth factor-beta(1), -beta(2), -beta(3), basic fibroblast growth factor and vascular endothelial growth factor expression in keratinocytes of burn scars. Eur Cytokine Netw 2000;11:233-39.
|